Expert opinion on childhood immunisation schedule: Diphtheria-tetanus-pertussis (DTP) vaccination
Current childhood vaccination schedules are the result of historical tradition, compliance with provision of health services and national vaccine registration. They have been designed on the basis of different needs related to how the healthcare system – but also the education system – is organised at national level. During the last decade, the availability of new combined vaccine products registered at EU level has allowed some convergence of the use of those vaccines.
The current schedules for vaccination below 24 months of age in Europe with acellular pertussis-containing vaccines can be divided into few distinct groups (variants of 3-5-11, 2-3-4, 2-4-6 months). There is greater variation in the number of booster doses for children at school age or during adolescence.
In order to facilitate the scientific discussion on such issue, ECDC asked a panel of experts for their scientific opinion on the use of the DTP vaccine.
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
5 Dec 2018 - The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
23 Nov 2018 - This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Programmatic management of latent tuberculosis infection in the European Union
15 Oct 2018 - Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).